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864 The Journal of Thoracic and CardioBackground: Flush perfusion with low-potassium dextran is the standard strategy in
clinical lung preservation. Despite improved outcome, endothelial cell injury and
surfactant dysfunction remain a significant problem after lung transplantation. The
radical scavenger glutathione has been shown to be responsible for the efficacy of
Celsior solution in lung preservation. We tested the hypothesis that the addition of
glutathione to low-potassium dextran might further improve graft function by
ameliorating ischemia-reperfusion injury.
Methods: In 12 domestic pigs, lungs were flush preserved with either low-potassium
dextran (n  6) or low-potassium dextran supplemented by 5 mmol glutathione (n
 6). Left single lung transplantation was performed after 24-hour storage in
low-potassium dextran at 8°C. After 15 minutes of reperfusion the right main
bronchus and pulmonary artery were crossclamped. Hemodynamic and respiratory
measures were recorded in 30-minute intervals for a total observation period of 7
hours. Bronchoalveolar lavage fluid was obtained from the native lung and 2 hours
after reperfusion from the graft. Bronchoalveolar lavage fluid and surfactant com-
position, and surfactant function analyses were performed. Neutrophil sequestration
was assessed by myeloperoxidase activity assay. Tissue water content was calcu-
lated from wet/dry weight ratios at the end of the experiment.
Results: In the low-potassium dextran group, 2 animals died during reperfusion.
After reperfusion, pulmonary vascular resistance (P  .01) and pulmonary artery
pressure remained lower in the glutathione/low-potassium dextran group, which was
associated with a higher cardiac output (P  .05) in this group. Also, the oxygen-
ation index at the end of the observation period was higher in the glutathione/low-
potassium dextran group compared with the low-potassium dextran group (430 
130 vs 338  184, respectively; P  .05). The graft water content representing
postreperfusion lung edema was not different between the 2 study groups. Alteration
of surfactant was less in the glutathione/low-potassium dextran group with a signifi-
cantly decreased small to large aggregate ratio (P  .03) versus low-potassium
dextran group. Myeloperoxidase activity was twice as high in the low-potassium
dextran group when compared with the glutathione/low-potassium dextran group
(glutathione/low-potassium dextran: 134  110 mU/g vs low-potassium dextran:
274  168 mU/g, P  .07).
Conclusion: The addition of glutathione to low-potassium dextran preservation
solution reveals beneficial effects on vascular function and surfactant composition in
transplanted lungs. Therefore, glutathione ameliorates ischemia-reperfusion injury in a
preclinical model of lung transplantation. Future studies are needed to evaluate this
promising modification in clinical lung transplantation.vascular Surgery ● September 2005
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TXIschemia-reperfusion (I/R) injury remains a serious is-sue in pulmonary transplantation.1,2 The use of low-potassium dextran (LPD) solution for pulmonary pres-
ervation has become a standard strategy in clinical lung
transplantation leading to improved outcome, as reported by
us and others.3-5 Recently, we demonstrated that the use of
Celsior solution leads to superior pulmonary-vascular pres-
ervation when compared with LPD in experimental lung
transplantation.6 Because I/R injury is mediated in part by
the generation of oxygen-derived radicals, oxidizing en-
zymes, or nitric oxide (NO),7 we addressed the beneficial
effect of Celsior preservation solution on pulmonary-
vascular function to the antioxidative capability of its addi-
tive, reduced glutathione (GSH). Because of the character-
istic inflammatory response to I/R in transplanted lungs,
depletion of reductive thiols (ie, GSH) may occur.8 Supple-
mentation of GSH has an inhibitory effect on oxygen-
derived radicals. This, consequently, preserves cellular
function and cell integrity. In addition, GSH enhances
endothelium-dependent NO release by improving the trans-
membrane transportation of NO into smooth muscle cells.8
However, in comparison with Celsior solution, LPD seems
to provide superior protection of the surfactant system be-
cause of its component dextran 40. As previously reported,
dextran 40 acts as an impermeant preventing extravasation
of water into the alveolar space, thereby preventing surfac-
tant inhibition.9 In addition, it protects the graft from intra-
vascular microthrombi formation by coating corpuscular
blood components.9 We hypothesized that the addition of
GSH to LPD solution further improves pulmonary preser-
vation in a preclinical model of single lung transplantation
compared with LPD alone.
Methods
The purpose of this study was to evaluate initial lung function after
24-hour cold ischemic preservation with LPD or GSH-enriched
LPD solution followed by a 7-hour observational reperfusion
period. In addition, surfactant function analysis was performed,
which has repeatedly been shown to be a sensitive parameter for
the quality of lung preservation.
Animal Care
All animals received humane care in compliance with the “Prin-
ciples of Laboratory Animal Care” and the “Guide for the Care and
Use of Laboratory Animals” prepared by the Institute of Labora-
tory Animal Resources, National Research Council, and published
by the National Academy Press, revised 1996. The study protocol
was reviewed, and all experiments were approved by the local
ethics committee of the Hannover Medical School.
Donor Procedure
In 12 female pigs (German Landrace; 24-33 kg), anesthesia was
induced by the application of azaperone (5 mg/kg, intramuscu-
larly), atropine (5 mg total dose, intramuscularly), and pentobar-
bital (1 mg/kg, intravenously). Animals were intubated and venti-
The Journal of Thoracilated in a pressure-controlled mode with a peak inspiratory
pressure of 30 cmH2O, a positive end-expiratory pressure of 5
cmH2O, and an FIO2 of 0.5. Anesthesia was maintained by con-
tinuous infusion of pentobarbital (5 mg · kg · h) and fentanyl (1
g · kg · h). After median sternotomy, the inferior and superior
venae cavae were encircled with ties and the pulmonary artery was
dissected from the ascending aorta. After systemic application of
heparin (300 IU/kg), a 5-mm cannula was inserted into the pul-
monary artery. Right heart inflow occlusion was performed, and
the left atrial appendage was excised. The pulmonary artery was
clamped and either 1 L of 4°C cold LPD (Perfadex, Vitrolife,
Gothenburg, Sweden) supplemented by 0.3 mL Tris-buffer or 1 L
of 4°C cold GSH-LPD (Sigma-Aldrich Laborchemikalien GmbH,
Germany) with 0.7 to 1.1 mL Tris-buffer was infused. The pH of
the preservation solution was adjusted using Tris-buffer to a target
level of 7.5. The intrapulmonary artery pressure was recorded
throughout the flushing period. A mean perfusion pressure of 16
mm Hg was maintained. The harvested lungs were stored in a
semi-inflated state in LPD at 4°C for 24 hours.
Porcine Single Lung Transplantation
In 12 female pigs (German Landrace; 23-32 kg), anesthesia was
induced and maintained as described. Recipient arterial pressure
was monitored by a carotid artery catheter, and pulmonary artery
hemodynamics were monitored by a Swan-Ganz catheter (7.5F,
Baxter Healthcare, Irvine, Calif). Cardiac output and extravasal
lung water were recorded with a femoral artery thermodilution
catheter connected to a cardiac output recording device (Picco
System; Pulsion Medical Systems AG, Munich, Germany). The
chest was entered through a left lateral thoracotomy in the fourth
intercostal space. Left pulmonary artery, lung veins, and bronchus
were dissected. After systemic administration of heparin (300
IU/kg), a left-sided pneumonectomy was performed. The graft was
transplanted with running polypropylene sutures used for all 3
anastomoses. After 10 minutes of reperfusion the right pulmonary
artery and right main bronchus were crossclamped.
Assessment of Hemodynamics and Lung Function
Right atrial and arterial and pulmonary artery pressures were
recorded online. Arterial and venous blood gas analyses were
performed in 30-minute intervals after reperfusion. Pulmonary
vascular resistance (PVR) was calculated. The system was cali-
brated by 3 repeated bolus injections of 10 mL of 8°C cold saline
solution into the jugular vein. Experiments were terminated by a
pentobarbital overdose after 7 hours of reperfusion.
Surfactant, Protein, and Phospholipid Analysis
A bronchoalveolar lavage in the native recipient lingula was per-
formed with 100 mL warmed isotonic saline solution before trans-
plantation. A second bronchoalveolar lavage of the lingula of the
transplanted lung was performed 2 hours after reperfusion. The
recovered bronchoalveolar lavage fluid (BALF) was centrifuged at
150g, and the cell-free supernatant was frozen at 80°C until
further analysis. From the cell pellet a manual differential cell
count was performed by standard techniques. From the cell-free
supernatant samples, phospholipid content was determined accord-
ing to the method described by Bartlett.10 Protein content was
measured according to the technique described by Lowry and
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the mean value was reported. Surfactant was isolated from BALF
by centrifugation at 48,000g for 60 minutes at 4°C. Phospholipid
determination of the pellet and the supernatant served for calcu-
lation of the small to large aggregate (SA/LA) ratio. Surfactant
function was determined by a pulsating bubble surfactometer
(Electronetics, Buffalo, NY) according to the technique described
by Enhorning.12 In brief, 40 L of the pelleted surfactant, which
had been adjusted to a phospholipid concentration of 1 mg/mL,
was filled into the sample chamber. The surface tension at minimal
bubble size (min) was recorded after 5 minutes of bubble pulsa-
tion at a rate of 20 cycles/min and a temperature of 37°C. Before
bubble pulsation was started the adsorption rate was determined as
surface tension 10 seconds after formation of a bubble (ads). All
analog data were digitalized and recorded.
Myeloperoxidase Activity Assay
Relative neutrophil sequestration into lung tissue was assessed by
a myeloperoxidase activity assay.13 Frozen lung tissue specimen
was homogenized in 1.5 mL of 0.02 mol/L potassium phosphate
buffer (pH 7.4). The suspension was centrifuged at 10,000g for 15
minutes. The supernatant was discarded, and the pellet was resus-
pended in 2 mL of 0.5% hexadecyltrimethylammonium bromide in
50 mmol/L potassium phosphate solution (pH 6.0) and homoge-
nized. Tissue was disrupted by sonication and 3 freeze-thaw cycles
(liquid nitrogen bath/37°C water bath). The suspension was cen-
trifuged at 10,000g for 15 minutes. Aliquots (0.1 mL) of superna-
tant were added to 1 mL of tetramethylbenzidine substrate system
(Sigma Chemical; St Louis, Mo) at pH 6.0. The change in absorp-
tion at 655 nm at 25°C over 3 minutes was recorded. Assays were
performed as repeated measures and results are expressed as
means in milliunits per gram.
Statistical Analysis
Data were expressed as mean  standard error of the mean.
Analysis of continuous data was performed using repeated-
measures analysis of variance (ANOVA). Data without repeated
Figure 1. PO2/FIO2 ratio in arterial blood samples drawn from the
left atrium over the 7-hour reperfusion period. LPD, Low-potas-
sium dextran; GSH, glutathione.measurements were analyzed by the 2-sided Student t test. All data
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(SPSS for Windows version 10.0; SPSS Inc, Chicago, Ill).
Results
Animal Survival
In the LPD group, 2 animals died of right heart failure
caused by severe reperfusion injury 2.5 and 4 hours after
reperfusion, whereas in the GSH-LPD group all 6 animals
survived for the entire experiment.
Hemodynamic and Respiratory Parameters
The arterial oxygenation index remained lower in grafts
preserved with LPD compared with GSH-LPD throughout
the observation time. At the end of the reperfusion period,
LPD-preserved lungs showed a lower PO2/FIO2 ratio of 338 
184 compared with GSH-LPD–preserved grafts (430 
130), as shown in Figure 1 (P  .01). Dynamic lung
compliance was comparable in both experimental groups
during the observation period. An early increase in PVR
after reperfusion resulted in right heart failure in 2 animals
in the LPD group. Whereas the 6 GSH-LPD–treated lungs
reached a maximum in PVR of 659  72 dyn · s · cm5,
LPD grafts showed significantly higher values with a peak
at 1573  621 dyn · s · cm5 (P  .01) after graft
reperfusion (Figure 2).
Lung Water Content
Lung tissue water content was significantly increased in
both groups at the end of the experiment compared with
control lungs. However, no statistical difference was
achieved between the LPD and GSH-LPD groups (wet/dry
ratio: LPD: 8.1  0.8 vs LPD-GSH: 7.5  3.3, P  .11).
BALF Analysis
BALF from native lungs showed normal cell counts with a
predominance of alveolar macrophages (86%) and approx-
imately 3.6% neutrophils (Table 1). After 2 hours of reper-
fusion, a reduced percentage of macrophages (80%  8.6%
LPD vs 73.3%  26.2% GSH-LPD, P  .57) combined
with a substantial increase in relative neutrophil count
(26.8%  28.0% LPD vs 21.3%  23.1% GSH-LPD, P 
.72) was observed in groups (Table 1). The relative increase
of neutrophils was equal in both study groups. However, the
total cell count in the GSH-LPD group remained substan-
tially lower after reperfusion when compared with native
controls and LPD-preserved lungs, indicating a lower abso-
lute neutrophil count in the GSH-LPD group (Table 1).
Differences between both groups and native lungs did not
reach statistical significance. The conversion of surface
active surfactant aggregates into surface inactive small sur-
factant aggregates is expressed by the SA/LA ratio. Control
lung values revealed a low quotient of 0.2  0.1. Surfactant
analysis after 2 hours of reperfusion revealed a 2- to 9-fold
increase of the SA/LA ratio (1.8  1.4 LPD vs 0.4  0.3
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with a trend toward higher levels in the GSH-LPD group (P
 .15) but a substantial amplification (control vs LPD, P 
.05) in the LPD group (Figure 3).
Surface Activity
After 5 minutes of pulsation time, the surface tension at
minimal bubble size was 1.6  0.6 mN/m in control lungs.
After 2 hours of reperfusion, surface tension increased to
8.0  6.7 mN/m in the LPD group, whereas in the GSH-
LPD group the increment appeared less pronounced with a
value of 5.2  8.6 mN/m. However, differences between
groups were not statistically significant.
Myeloperoxidase Activity
Myeloperoxidase activity in lung tissue reflects sequestra-
tion of neutrophil granulocytes. Tissue samples of control
lungs showed a low myeloperoxidase activity (7.3  5.6
mU/g). After 7 hours of reperfusion a substantial increase in
myeloperoxidase activity to the 13-fold (GSH-LPD) and
38-fold (LPD) was seen compared with control lungs (P 
.04). Differences between both study groups did not reach
Figure 2. PVR over 7 hours of reperfusion. Clamping the right
main pulmonary artery caused a significant increase in PVR in
both groups. Differences in PVR over 7 hours were statistically
significant between both groups (P .01). LPD, Low-potassium
dextran; GSH, glutathione; PVR, pulmonary vascular resistance;
Anova, analysis of variance.
TABLE 1. Differential cell count obtained from BALF 2
hours after reperfusion
LPD LPD-GSH Control
Macrophages (%) 80.0 8.6 73.3 26.2 86.0 11.6
Neutrophils (%) 26.8 28.0 21.3 23.1 3.6 5.0
Cell count (cells/L) 122.4 94.6 15.5 5.8 415.0 280
LPD, Low-potassium dextran; GSH, glutathione. Data are expressed as
mean  standard error of mean. Values did not differ significantly.
The Journal of Thoracistatistical significance (274  168 mU/g, LPD vs 94  89
mU/g, GSH-LPD; P  .06) (Figure 4).
Discussion
In the pursuit of further improvement in lung preservation,
many strategies have been developed and described.14,15 In
this study, the effect of a GSH as an additive to LPD
solution on posttransplant graft function, I/R injury, and
surfactant function were compared with LPD only, which is
currently the gold standard in clinical lung preservation.4,5
We used our previously described preclinical porcine single
lung transplant model, which has the obvious advantage of
reflecting the clinical situation more precisely than small
animal transplant models.16 We wanted to inflict a major
ischemic injury on the graft, and therefore a 24-hour period
of cold ischemic preservation was chosen. The model in-
cludes a 7-hour graft reperfusion period, throughout which
repeated hemodynamic, laboratory, and histologic measure-
ments and examinations were performed. Therefore, this
Figure 3. SA/LA ratio of the BALF phospholipid composition 2
hours after reperfusion compared with control BALF collected
from recipient native lungs. SA/LA, Small to large aggregate; LPD,
low-potassium dextran; GSH, glutathione.
Figure 4. Myeloperoxidase activity of lung tissue after termina-
tion of the experiment to control tissue collected from recipient
native lungs. LPD, Low-potassium dextran; GSH, glutathione.
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transplanted lungs, which is a major contributor to early
mortality in clinical lung transplantation.17High potassium-
type solutions such as Euro-Collins have initially been
applied for lung graft preservation. We and others, however,
have repeatedly reported on the disadvantages of Euro-
Collins– based lung preservation and have specifically
shown a superior effect of LPD on endothelial lung injury
and surfactant function in the transplanted lung, which is
associated with a corresponding improvement of I/R
injury.18,19 Thus, the introduction of the extracellular type
LPD solution significantly improved the outcome in exper-
imental lung preservation with prolonged cold ischemic
times up to 24 hours as well as clinical outcome after lung
transplantation.4,5,20-22
We recently demonstrated that Celsior, a GSH-based
preservation solution, provides reliable pulmonary protec-
tion.6 Thereby, Celsior led to improved protection of pul-
monary vascular function, whereas LPD was more protec-
tive of the pulmonary surfactant system. We speculated that
the improvement in vascular function after Celsior applica-
tion had to be addressed to its additive, GSH, which is a
potent oxygen free radical scavenger.8 In this study we
examined the effect of reduced GSH as an additive to LPD
for pulmonary preservation on posttransplant lung function
after extended cold ischemic preservation using a preclini-
cal large animal model. In its action as a radical scavenger,
GSH protects the endothelium from oxygen-derived free
radical damage.23,24 Furthermore, it reduces neutrophil se-
questration and acts as a potent vasodilator by improving
NO bioavailability and liberation to smooth muscle cells.
Compared with LPD-preserved lungs, Celsior-preserved
grafts demonstrated improved vascular function by the re-
duction of both pulmonary artery pressure and PVR. How-
ever, surfactant function was better preserved in LPD-
preserved lungs. Ideally, GSH-enriched LPD may have the
beneficial effect of improving both vascular and surfactant
function in transplanted lungs. Indeed, we showed in this
study that crucial parameters of posttransplant pulmonary
function such as systemic oxygenation and endothelial func-
tion were superiorly protected by GSH-LPD compared with
LPD-preserved lungs. Furthermore, surfactant function was
also better preserved than with LPD alone, as demonstrated
by the SA/LA ratio. With regard to the other end points,
GSH remarkably improved the protective action of LPD.
Whereas in the LPD group 2 of 6 animals died 2.5 hours and
4 hours after reperfusion from right ventricular failure
caused by I/R injury-related increase of PVR, the entire
GSH-LPD cohort survived for the 7-hour observation pe-
riod. Parameters of posttransplant lung function, such as the
FIO2/PAO2 ratio, were significantly improved in the GSH
group accompanied by significantly decreased PVR and
pulmonary artery pressure, and an increased cardiac output.
868 The Journal of Thoracic and Cardiovascular Surgery ● SeptAt the end of the 7-hour reperfusion period, the pulmo-
nary water content as assessed by wet/dry lung weight
ratios was larger in the LPD group. Neutrophil seques-
tration remained lower to some extent in the LPD-GSH
group than the LPD group, respectively. Surfactant ac-
tivity showed uniform impairment in both groups as
shown by an increased minimal surface tension (min) as
determined in the pulsating bubble surfactometer. Also,
an increase of the SA/LA ratio of the phospholipid frac-
tion was seen. However, overall only mild surfactant
dysfunction was observed in both study groups.
In previous studies we extensively evaluated preserva-
tion solutions for lung preservation. We and other clinical
lung transplant program investigators are currently focusing
on the extension of donor criteria to increase the number of
transplantable donor organs. Therefore, an increasing num-
ber of elderly or “marginal” donors are accepted for trans-
plantation.25 This, however, necessitates optimal preserva-
tion to exclude the additional confounding factor of
preservation injury. Therefore, we strongly believe that the
issue of lung preservation is even more important in lung
transplantation than ever before. We strive to improve our
current standard in lung preservation toward extended isch-
emic times, which will ultimately help to procure organs
throughout Europe. This study is our first attempt to im-
prove our current clinical standard in lung preservation. We
are encouraged by our results, and the improvement after
lung transplantation with the application of the relatively
simple modification of LPD with GSH is remarkable. On-
going work in our laboratory is now directed toward eluci-
dating the mechanisms involved.
Conclusion
GSH supplementation of LPD is a reasonable strategy to
further improved lung preservation leading to superior graft
function and reduced posttransplant I/R injury. The use of
GSH-enriched LPD in clinical lung transplantation seems to
be a desirable approach especially with regard to prolonged
ischemic preservation.
We thank Ms. Petra Oppelt for reviewing statistical analysis as
a biostatistician. We furthermore acknowledge that this study
would not have been possible without the professional help of the
Hannover Experimental Lung Transplant Group.
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